Clinical trials: Evaluation of SpO2 Performance
- Condition Evaluation of SpO2 Performance
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Evaluation of SpO2 Performance
Feasibility and Performance Evaluation of INVSENSOR00024
This is a prospective, non-randomized, single arm study design to evaluate SpO2 performance of the INVSENSOR00024 sensors in the neonatal population in a clinical environment using convenience sampling.
- Trial name
- NCT03831282
- Testing
- RD SET Neo SpO2
- Where
- United States
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- Masimo Corporation
Evaluation of SpO2 Performance
Feasibility and Performance Evaluation for INVSENSOR00024
This is a prospective, non-randomized, single arm study design to evaluate SpO2 performance of the RD SET Neo investigational pulse oximeter sensors in the neonatal population using convenience sampling in a clinical environment.
- Trial name
- NCT03570255
- Testing
- RD SET Neo SpO2
- Where
- United States
- Volunteers
- 28 people, healthy volunteers welcome
- Sponsor
- Masimo Corporation
SpO2 (Peripheral Oxygen Saturation) Measurement Validation, SpO2
SpO2 Infant and Pediatric Study
This study evaluates the pulse oximetry (SpO₂) sensor for clinical performance, form, and fit in hospitalized infants and children (28 days to 12 years).
- Trial name
- SpO2 Peds (NCT07615738)
- Testing
- SpO2 Sensor
- Where
- United States
- Volunteers
- 180 people
- Sponsor
- GE Healthcare